Cancer stem cells as targets for DC-based immunotherapy of colorectal cancer

The therapy of colorectal cancer (CRC) patients is often unsuccessful because of the presence of cancer stem cells (CSCs) resistant to conventional approaches. Dendritic cells (DC)-based protocols are believed to effectively supplement CRC therapy. Our study was aimed to assess how the number and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Szaryńska, Magdalena, Olejniczak, Agata, Kobiela, Jarosław, Łaski, Dariusz, Śledziński, Zbigniew, Kmieć, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089981/
https://www.ncbi.nlm.nih.gov/pubmed/30104575
http://dx.doi.org/10.1038/s41598-018-30525-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089981/
https://www.ncbi.nlm.nih.gov/pubmed/30104575
http://dx.doi.org/10.1038/s41598-018-30525-3

Ejemplares similares